Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium for Succinylcholine-Induced Postoperative Myalgia
NCT03476044Phase 3Completed
- Sponsor
- Assiut University
- Start
- Jun 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of selenium in Postoperative myalgia (POM), sponsored by Assiut University. Started Jun 2018; status: completed.
02
Drugs
selenium
03
Conditions
Postoperative myalgia (POM)
Beyond the preview
Go deeper on NCT03476044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476044.